Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS (2002) Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c
PlexusDx tirzepatide comes from licensed 503A compounding pharmacies and meets the same stability standards as commercial formulations when properly stored
Semaglutide has emerged as a promising treatment for weight management at Big Apple Medical Care
the GLP-1 and GIP components of retatrutide are thought to offset this effect, but this balance is still being characterised in ongoing trials
Tree Physiol 39:11491158
discontinue if weight loss is less than 5% Regular weight measurements and BMI calculations Monitoring for adverse effects, particularly gastrointestinal symptoms Blood pressure and cardiovascular risk factor assessment Periodic blood tests to monitor metabolic parameters For patients with diabetes who are taking insulin or sulfonylureas, doses of these medications may need to be reduced when starting GLP-1 receptor agonists to prevent hypoglycaemia
